Life Sciences Leaders

In this episode of Life Science Leaders, our host Lissa, Director of Kaizen Life Sciences speaks with Mark Lightowler, the Founder and CEO of Phorix. 

We dive into behaviour change and how it can drive innovation, such as how the pharmaceutical industry improves and detects issues earlier and deliver better patient outcomes with technology. 

Phorix is a behavioural change design agency that helps clients understand and change their customer's behaviour using behavioural science innovation & communications. 

Listen to the episode for more fascinating insights into how understanding human behaviour can improve outcomes in the pharmaceutical industry. 

#pharaceuticals #pharma #medtech #behaviourchange #lifesciences 

The first episode of Pharma Series listens in on a conversation between our host Lissa, Director of Kaizen Life Sciences, and Jenn Fenwick, CEO of Rebel Road Coaching and Onboarding. 

This episode delves into the story of how Jenn came to set up her company, offering support and guidance to those in leadership positions. 

The journey to success is never without challenges, yet Rebel Road Coaching and Onboarding strive to make that journey smoother for leaders at all levels. 

Listen in to our new Pharma Series on the Life Science Leaders Podcast and get ready to be inspired, motivated and captivated by each episode. 

In episode 3 of Life Science Leaders, Chris Stevens talks us through the concept of evidence-based management, and how he uses it to support his clients in the pharmaceutical and medical device industries. 

Chris is the CEO at Cambridge Healthcare Research, a consulting firm that provides strategic decision support and market insight to life science companies. During the podcast, Chris talks how about how evidence-based management helps inform the decision-making process, how it’s built into Cambridge Healthcare Research’s company culture, and the impact it can have on the wider life science industry. 

A must-listen for life science leaders looking for a fresh approach to management. 

Welcome to the Life Sciences Leaders series podcast, we will be talking to a variety of senior leaders covering topics that are relevant to what is happening in the industry right now.

‘Within the next 10 years, over 70% of the workforce will be either a millennial or a Generation Z.’

Bringing new ideas, beliefs, and expectations, this generational shift will completely alter the way we work. As a result, employee power will become much stronger, giving the workforce a greater ability to demand things of their employers.

This is the prediction of Stuart Neilson, Senior Partner at Future Work Forum, our latest guest on Life Science Leaders. 

After leading the Forum’s marketing strategy for most of last year, Stuart believes that employers who focus solely on profit will become unpopular in favour of those who invest in wider issues, such as society and the planet.

Have a listen to the full episode for more fascinating insight and predictions about the evolution of the workplace.

Welcome back to the Life Sciences Leaders series podcast, we will be talking to a variety of senior leaders covering topics that are relevant to what is happening in the industry right now.

In episode 1 of series 2 of the Life Science Leader, we speak with Rahul Kapoor - Chief Commercial Officer at Arc and Medicspot. We discuss the changes in technology that have accelerated during the pandemic.  And how the medical device sectors differing from the pharma sector in a post-COVID world. 

Life Sciences Leaders series podcast, we will be talking to a variety of senior leaders covering topics that are relevant to what is happening in the industry right now.

In episode 4 of Life Science Leader, we speak with Mike Karim the CEO of Oxford Endovascular. We discuss the journey of a spin out company in the life science sector. 

He knew when they were spinning out that they had had great technology. Mike also knew he had to have a fantastic team that would help develop the concept further to be successful.

Listen to our new podcast, Life Science Leaders, to hear more about life in a spin out company and its many challenges including fundraising. 

Life Sciences Leaders series podcast, we will be talking to a variety of senior leaders covering topics that are relevant to what is happening in the industry right now.

In episode 3 of Life Science Leader, we speak with Pierre van Weperen the Managing Director at Grow Biotech about life in a startup pharmaceutical company. 

Having gone from a large corporate company to a smaller start up company, Pierre gives us some great insight on building growth in the right way. Without going too quickly and losing all control.

‘Every now and then you have to stop, look and get the team together.’

It’s easy in small companies to have top management making all the decisions, being unchallenged or questioned. The CEO says do one thing, everyone follows suit. 

Making decisions that aren’t necessarily right, which can ultimately lead to failure in small businesses.

Listen to our new podcast, Life Science Leaders, to hear more about life in a startup company.

Life Sciences Leaders series podcasts, we will be talking to a variety of senior leaders cover topics that are relevant to what is happening in the industry right now.

In our second episode, we speak with Rick Leah, the Founder and Managing Director at Callisto Life Science Partners about the importance of pre commercialise planning and not spreading the product too thinly across too many markets.

Download the second episode of our new podcast, Life Sciences, to how to launch and to be well-positioned in an ever-evolving market.

The Medical Device Regulation seems intimidating to those of us who have been in the life sciences sector for decades.

So what hope do early-stage companies have of deciphering its bulk and ensuring they are compliant.

In the first of Kaizen Life Sciences “Life Sciences Leaders” podcast series, I talk to Paul Hercock - CEO & co-founder at Mantra Medical Ltd, about how companies in the life sciences sector can break down the MDR into more manageable action points.